StockData
Nexentis Technologies Inc. logo

Nexentis Technologies Inc. (NXTS) stock

NXTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$1.99−0.22 (-9.95%)

Close on Nov 16, 2026Market cap $2.89MP/E –Yield –

Nexentis Technologies r&d expenses

Research and development expenses are spending on new products and technology.

Nexentis Technologies's R&D Expenses for the twelve months ending Jun 30, 2026 was $798.00K, up 110.6% year over year. For fiscal 2025 it was $179.00K, down 51.5% from the year before. The highest annual figure on record is $1.94M in fiscal 2023.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$179.00K-51.5%
FY2024Dec 31, 2024$369.00K-81.0%
FY2023Dec 31, 2023$1.94M+151.4%
FY2022Dec 31, 2022$770.83K+43.1%
FY2021Dec 31, 2021$538.68K+29.2%
FY2020Dec 31, 2020$417.00K-32.3%
FY2019Dec 31, 2019$615.62K+72.4%
FY2018Dec 31, 2018$357.08K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$373.00K+4044.4%
Q1 FY2026Mar 31, 2026$275.00K+1275.0%
Q4 FY2025Dec 31, 2025$98.00K-70.4%
Q3 FY2025Sep 30, 2025$52.00K+173.7%
Q2 FY2025Jun 30, 2025$9.00K+50.0%
Q1 FY2025Mar 31, 2025$20.00K-82.8%
Q4 FY2024Dec 31, 2024$331.00K+203.6%
Q3 FY2024Sep 30, 2024$19.00K-98.9%
Q2 FY2024Jun 30, 2024$6.00K-64.4%
Q1 FY2024Mar 31, 2024$116.00K-2.4%
Q4 FY2023Dec 31, 2023$109.03K-56.3%
Q3 FY2023Sep 30, 2023$1.69M+753.0%
Q2 FY2023Jun 30, 2023$16.86K-85.1%
Q1 FY2023Mar 31, 2023$118.91K-43.2%
Q4 FY2022Dec 31, 2022$249.59K+42.1%
Q3 FY2022Sep 30, 2022$198.50K+198.6%
Q2 FY2022Jun 30, 2022$113.38K-50.0%
Q1 FY2022Mar 31, 2022$209.36K+200.0%
Q4 FY2021Dec 31, 2021$175.68K+130.6%
Q3 FY2021Sep 30, 2021$66.47K-24.0%
Q2 FY2021Jun 30, 2021$226.74K+136.9%
Q1 FY2021Mar 31, 2021$69.79K-55.7%
Q4 FY2020Dec 31, 2020$76.19K-68.8%
Q3 FY2020Sep 30, 2020$87.47K-42.6%
Q2 FY2020Jun 30, 2020$95.71K+9.8%
Q1 FY2020Mar 31, 2020$157.64K+19.6%
Q4 FY2019Dec 31, 2019$244.22K–
Q3 FY2019Sep 30, 2019$152.40K–
Q2 FY2019Jun 30, 2019$87.18K–
Q1 FY2019Mar 31, 2019$131.83K–

More Nexentis Technologies figures

See a number that looks wrong?